ADAI News & Events
February 3, 2026
ADAI Lunch & Learn: Update on Neuromodulation Techniques and Applications (Feb. 26, 2026, 12pm PT)
Join ADAI on February 26, 2026 (12-1pm PT) for the next session in our (virtual) Lunch & Learn series! In this session, Randall Espinoza, MD, MPH, Medical Director of the UW Garvey Institute Center for Neuromodulation, will explore current FDA-approved neuromodulation devices—medical technologies that use electrical pulses, magnetic fields, or other techniques to treat various…
February 2, 2026
Center for Novel Therapeutics in Addiction Psychiatry (NTAP) Joins ADAI!
ADAI is pleased to announce that the UW Center for Novel Therapeutics in Addiction Psychiatry (NTAP) has joined our institute! NTAP’s mission is to “create powerful news ways of treating people struggling with alcohol, opioid, tobacco, and other addictions by combining psychedelic compounds with evidence-based behavioral interventions.” One of their current studies, for example, is…
January 30, 2026
RECORDING AVAILABLE: ADAI Lunch & Learn: Of Mice and Misuse: Preclinical Modeling of Fentanyl Use Disorder
This session was hosted in January 2026. Find the recording here! Kevin Coffey, PhD, is a Research Assistant Professor in UW Psychiatry and Behavioral Sciences and a MIRECC Investigator at the VA Puget Sound. His lab aims to identify the neural mechanisms underlying substance use disorders and maladaptive decision making. Dr. Coffey’s current focus is on…
January 29, 2026
RECORDING AVAILABLE: Washington Community Drug Checking Network (Jan. 27, 2026, 11am PT)
Update: This event was held on January 27, 2026. The slides & recording are now available. Join ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) for the first Washington State Community Drug Checking Network (CDCN) webinar of 2026! This session will provide an overview of the network and its role in supporting drug…
January 27, 2026
ADAI in the News: People with Psychotic Disorders Link Cannabis Use to Physical Ills (UW Medicine News & KUOW)
People who have psychotic disorders, such as schizophrenia, and who also use cannabis report experiencing a wider range of health problems than previously documented. In a study recently described in a paper in Community Mental Health Journal, ADAI Research Associate Professor Beatriz Carlini, PhD, MPH, and colleagues analyzed survey responses from 4,144 Washington State cannabis…
January 22, 2026
New ADAI Publications on Cannabis, Workforce Development, and Treatment Services in Carceral Settings
Here’s what our faculty and staff have been up to lately: People with psychotic disorders are the most vulnerable to cannabis adverse health outcomes: A study in WA State, USA. Carlini BH, Williams JR, Garrett SB, Hammond D. Community Mental Health Journal 2026 (in press). This paper describes a study that compared negative health effects…
January 13, 2026
ADAI Assistant Professor Mandy Owens Named to UW Research Impacts Advocates Cohort
Mandy Owens, PhD, an assistant professor with ADAI in the UW Department of Psychiatry & Behavioral Sciences, has been selected to join the inaugural Research Impact Advocates cohort organized by the UW Office of Research. Dr. Owens’ work aims to improve services for people who use alcohol and drugs with a focus on those involved…
Webinar: What’s the Latest? Opioid Recovery & Care Access (ORCA): A Closer Look (Feb. 10, 12pm PT)
Building on January’s What’s the Latest? session, this webinar will dive deeper into DESC’s ORCA Center—a 24/7, judgment-free space for recovery after overdose and initiation of medications for opioid use disorder (MOUD). You’ll learn about the care ORCA provides, its person-centered approach, and how the team works together to deliver timely, compassionate support to the…
January 8, 2026
RECORDING AVAILABLE: Behind the Design of a 24/7 Post-Overdose and MOUD Initiation Center (the ORCA Center)
On January 7, 2026 (12-1pm PT), the State Opioid Response (SOR) team hosted the second installment of their What’s the Latest? series, a quarterly webinar series addressing innovative approaches related to medications for opioid use disorder (MOUD). This session highlighted the Opioid Recovery Care Access (ORCA) Center—a 24/7, judgment-free space for recovery after overdose, MOUD…
December 29, 2025
Northwest ATTC Webinar: Outreach-Based Long-Acting Injectable Buprenorphine (Jan. 21, 2026, 12-1pm PT)
Join presenters Jeremy Hoog, RN, BSN, MA, and Carson Bell, MPH of the Downtown Emergency Service Center (DESC) in Seattle, WA for the first Northwest ATTC webinar of 2026! Outreach-Based Long-Acting Injectable Buprenorphine: A Viable Pathway to Closing OUD Treatment Gaps January 21, 2026 (12-1pm PT) Overdose deaths involving fentanyl increased by 45% from 2021 to 2022 in…
Previous page Next page
